Long-term effects of daclizumab-beta in patients with relapsing multiple sclerosis in EXTEND. Interim results from treatment for up to 6 years.

Authors

• Ludwig Kappos
• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow
• Douglas Arnold
• Randy Robinson
• Becky Parks
• Huaihou Chen
• Sami Fam

Document Type

Presentation

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences